Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Expert Review of Hematology|June 23, 2025
Obecabtagene autoleucel, a novel CD19-directed CAR T-cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia: the future for reducing toxicity and T-cell exhaustion?Jean A Yared, Ariel Fromowitz, Mehmet Kocoglu, et al.
Transplantation and Cellular Therapy|June 26, 2026
Predictors of Rehabilitation Utilization After CAR T-Cell TherapyHanan Alharthy, Abdulaziz Abu-Haimed, Renu E Thomas, et al.
Biorxiv : the Preprint Server for Biology|February 19, 2024
Broad de-regulated U2AF1 splicing is prognostic and augments leukemic transformation via protein arginine methyltransferase activationMeenakshi Venkatasubramanian, Leya Schwartz, Nandini Ramachandra, et al.
Leukemia & Lymphoma|December 27, 2024
Transforming growth factor beta receptor type I (TGF-βRI) kinase inhibitors IOA-359 and IOA-360 stimulate erythropoiesis in MDSNandini Ramachandra, Charan Thej Reddy Vegivinti, Srabani Sahu, et al.
Science Translational Medicine|May 7, 2025
Splicing regulatory dynamics for precision analysis and treatment of heterogeneous leukemiasMeenakshi Venkatasubramanian, Leya Schwartz, Nandini Ramachandra, et al.
Haematologica|October 16, 2025
CNS infiltration by zamtocabtagene autoleucel tandem CD20/CD19 CAR T cells leading to complete remission in a patient with primary CNS lymphomaNancy M Hardy, Jean A Yared, Tim Luetkens, et al.
Cancer Cell|November 28, 2021
Efficacy of booster doses in augmenting waning immune responses to COVID-19 vaccine in patients with cancerLauren C Shapiro, Astha Thakkar, Sean T Campbell, et al.
JAMA Oncology|August 17, 2023
Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19Shuchi Gulati, Chih-Yuan Hsu, Surbhi Shah, et al.
Pageof 1